Chronic fatigue syndrome (CFS) is a unique and perplexing long–‐term, disabling illness that affects up to 10 million people in the United States.
CFS is found in both males and females of all races and socioeconomic levels, but seems to appear more often in middle–‐aged women.
There are a wide variety of symptoms, arising from both the body and the mind, including the following:
- Fatigue (100%)
- Low-grade fever
- Muscle pain
- Sleep disturbance
- Impaired mental function
- Depression
- Headache
- Allergies
- Sore throat
- Anxiety
- Muscle weakness
- Stiffness
- Visual blurring
- Joint pain
- Dizziness
- Diarrhea
- Cough
- Night swears
- Painful lymph nodes
Research shows that most patients have various types of long term stress prior to the onset of fatigue and other symptoms. Stress up-‐regulates the sympathetic nervous system releasing epinephrine and other hormones of acute stress. Also, the adrenal glands increase production of cortisol, the hormone of chronic stress.
The body is in chronic “danger” and long term projects governed by the parasympathetic nervous system, such as digestion, hormone production and immunity are reduced in order to insure survival. As Dr Sapolsky says in his book, “You don’t paint the garage when a hurricane is headed toward the house”.
Adrenaline and cortisol are designed for short-‐term survival action, not continuous release. Over time these potent hormones weaken the immune system, reducing its power to fight viruses, bacteria, fungi and other microbes, while allergies to environmental proteins, foods, and inhalants increases. This is called a Th1 to Th2 shift and sets the stage for chronic infections such as Epstein-‐Barr virus or HHV-‐6.
Later on as the disease progresses, the stress system begins to fail and cortisol levels fall, further weakening the immune system and reducing energy throughout the mind and body.
CFS patients have a common pattern of immune disturbances: low levels of natural killer cells, increased antibodies to a variety of viruses, increased levels of circulating immune complexes, increased levels of certain cytokines, especially interleukin-‐6, reduced interferon gamma production, and altered helper/suppressor ratios.
In addition, 2-‐5A synthetase is an enzyme, which induces the production of interferon in response to viral infection, is often elevated. This effect reduces interferon levels and the ability of the immune system to defend against viral infection.
Indeed, immune weakness and the inability to respond to chronic infection appear to be an essential feature of CFS. Dr. Garth Nicholson has shown that 60% of CFS patients have mycoplasma infections. Mycoplasma species seem to hide in the body and are often difficult to diagnose. In addition they do not always respond to antibiotic therapy.
Dr. Joseph Brewer is an infectious disease specialist with a lot of experience with CFS patients. He has found that the immune profile for people infected with human herpes virus 6 (HHV-‐6) is very similar to patients with CFS. HHV-‐6 infection is also difficult to diagnose and drugs that are used to treat the infection often have significant side effects.
Recently, he has been using certain forms of transfer factor to treat HHV-‐6 infections in CFS patients. Transfer factor therapy usually produces a significant reduction in symptoms, as well as increased levels of natural killer cells, but the treatment must be continued indefinitely or relapse may occur. 2
Brain imaging studies, such as SPECT scans show reduced blood flow to certain parts of the brain, which reflects hormonal imbalances, inflammatory cytokines and autonomic nervous system disturbances. These brain effects contribute to fatigue, poor concentration, altered memory, sleep problems and more.
Mindbody healing focuses on restoring the natural wisdom and balance of the body using vitamins, minerals, herbs and other natural therapies, such as the following:
- Hormone deficiencies, including cortisol, DHEA and thyroid,
- Nutrient deficiencies, such as magnesium, B vitamins, especially B12, amino acids, vitamin C, folic acid, fatty acids such as EPA, minerals like zinc and CoEnzyme Q10,
- Digestive problems, including delayed onset IgG mediated food allergies, intestinal overgrowth of Candida and other yeast species, and increased gut permeability,
- Chronic infections with viruses, bacteria and fungi,
- Liver detoxification impairments,
- Increased body burden of chemical toxins (for example pesticides and solvents) and heavy metals such as mercury, lead, cadmium and arsenic,
- Deficiencies in the essential detoxification enzyme glutathione, which is low in 50% of CFS patients,
- Disordered fat metabolism with low levels of acylcarnitine, which reduces fat as a mitochondrial fuel, thereby causing patients to crave carbohydrates and gain weight,
- Mitochondrial dysfunction with reduced levels of the cellular energy molecule, ATP.
- Hypoxemia, or low levels of blood oxygen,
Another important piece to the CFS puzzle has recently been discovered. Doctors at Hemex Laboratories in Phoenix, Arizona, and other researchers have found that infection with mycoplasma and other stealth pathogens such as chlamydia, as well as some species of viruses such as EBV, CMV, HHV6 and possibly even fungi like Candida, can activate the immune and blood coagulation systems so as to produce increased levels of blood coagulation.
The blood becomes viscous or thicker, thereby reducing blood flow and oxygen delivery to the tissues of the body. With less blood flow and oxygen to support normal metabolism, many cells in the organs of the body begin to function at reduced levels, thereby offering an explanation for the numerous symptoms seen in patients with illnesses like CFS.
This newly discovered syndrome is called Immune System Activation of Coagulation, or ISAC, and it causes a thin layer of fibrin (blood clotting material) to be layered along the inner lining of the blood vessels, which not only reduces blood flow to tissues but also seems to hide stealth pathogens, like mycoplasma, which can live in the cells of the blood vessels. This may account for the difficulty in diagnosing stealth infections.
In a pilot study on 20 patients with CFS/FMS, 90% of them had evidence of increased blood coagulation, or ISAC.
Once the ISAC syndrome is identified, then anti‐coagulant therapy will dissolve the fibrin coating on the inner lining of the blood vessels, thereby allowing more blood flow and elimination of many symptoms throughout the body. Anti-‐coagulant therapy not only relieves chronic CFS symptoms, it also may cause the stealth pathogens to be exposed in the body, thereby allowing for diagnosis and treatment of the underlying infection.
As patients begin to feel better physically, the next step is to continue the healing process into the realm of consciousness. This is where many people, including physicians, get a little uncomfortable, as they still believe that the body and the mind are separate; you treat one or the other.
The future of medicine is based on the recognition of the unity of mind and body. All illnesses are psychosomatic as conscious and unconscious factors are involved in every aspect of body function. Any treatment program that ignores precipitating psychological factors is incomplete. CFS is a classic mindbody disorder and demands deeper levels of healing.
Dysfunctional beliefs, suppressed emotions, chronic stresses, depression, anxiety, impaired concentration and memory, are woven into the symptoms of CFS.
Heart Rate Variability testing is an objective measure of stress in the body and allows them to gradually improve parasympathetic activity and reduce sympathetic arousal as they 3 progress in mindbody healing.
Counseling, emotional release, inner child writing, meditation, exercise are some of the tools available for the most important aspect of healing: improved self-‐knowledge, spiritual understanding and the experience of peace and happiness. Thus illness has served its purpose, which is healing.